Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database.

IF 1.8 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Expert Review of Cardiovascular Therapy Pub Date : 2024-04-01 Epub Date: 2024-03-12 DOI:10.1080/14779072.2024.2329720
Frederick Berro Rivera, Sung Whoy Cha, Mara Bernadette Liston, Sonny Redula, Nathan Ross B Bantayan, Nishant Shah, Mamas A Mamas, Annabelle Santos Volgman
{"title":"Sex differences in trends and in-hospital outcomes of acute myocardial infarction in patients with familial hypercholesterolemia: insights from a large national database.","authors":"Frederick Berro Rivera, Sung Whoy Cha, Mara Bernadette Liston, Sonny Redula, Nathan Ross B Bantayan, Nishant Shah, Mamas A Mamas, Annabelle Santos Volgman","doi":"10.1080/14779072.2024.2329720","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sex differences in clinical outcomes following acute myocardial infarction (AMI) are well known. However, data on sex differences among patients with familial hypercholesterolemia (FH) are limited. We aimed to explore sex differences in outcomes of AMI among patients with FH from a national administrative dataset.</p><p><strong>Research design and methods: </strong>We utilized the National Inpatient Sample to identify admissions with a primary diagnosis of AMI and a secondary diagnosis of FH. Our primary outcome of interest was in-hospital mortality; secondary outcomes were performance of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), respiratory complications, use of inotropes, use of mechanical circulatory support (MCS), bleeding complications, transfusion and facility discharge. We adjusted for demographics (model A), comorbidities (model B), and intervention (model C).</p><p><strong>Results: </strong>Between October 2016 and December 2020, 5,714,993 admissions with a primary diagnosis of AMI were identified, of which 3,035 (0.05%) had a secondary diagnosis of FH. In-hospital mortality did not differ between men and women (Model C, adjusted OR = 0.85; 95% CI 0.28-2.60, <i>p</i> = 0.773). There was no sex difference in the secondary outcomes.</p><p><strong>Conclusion: </strong>Despite generally being older and having more comorbidities, women with FH fair equally with men with FH in terms of mortality during AMI admission.</p>","PeriodicalId":12098,"journal":{"name":"Expert Review of Cardiovascular Therapy","volume":" ","pages":"193-200"},"PeriodicalIF":1.8000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Cardiovascular Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14779072.2024.2329720","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sex differences in clinical outcomes following acute myocardial infarction (AMI) are well known. However, data on sex differences among patients with familial hypercholesterolemia (FH) are limited. We aimed to explore sex differences in outcomes of AMI among patients with FH from a national administrative dataset.

Research design and methods: We utilized the National Inpatient Sample to identify admissions with a primary diagnosis of AMI and a secondary diagnosis of FH. Our primary outcome of interest was in-hospital mortality; secondary outcomes were performance of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), respiratory complications, use of inotropes, use of mechanical circulatory support (MCS), bleeding complications, transfusion and facility discharge. We adjusted for demographics (model A), comorbidities (model B), and intervention (model C).

Results: Between October 2016 and December 2020, 5,714,993 admissions with a primary diagnosis of AMI were identified, of which 3,035 (0.05%) had a secondary diagnosis of FH. In-hospital mortality did not differ between men and women (Model C, adjusted OR = 0.85; 95% CI 0.28-2.60, p = 0.773). There was no sex difference in the secondary outcomes.

Conclusion: Despite generally being older and having more comorbidities, women with FH fair equally with men with FH in terms of mortality during AMI admission.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
家族性高胆固醇血症患者急性心肌梗死的趋势和院内预后的性别差异:大型国家数据库的启示。
背景:急性心肌梗死(AMI)后临床结果的性别差异已众所周知。然而,有关家族性高胆固醇血症(FH)患者性别差异的数据却很有限。我们的目的是从一个全国性的行政数据集中探讨家族性高胆固醇血症患者在急性心肌梗死结局方面的性别差异:我们利用全国住院病人抽样来确定主要诊断为急性心肌梗死和次要诊断为 FH 的住院病人。我们关注的主要结果是院内死亡率;次要结果是经皮冠状动脉介入治疗(PCI)、冠状动脉旁路移植术(CABG)、呼吸系统并发症、肌注的使用、机械循环支持(MCS)的使用、出血并发症、输血和出院。我们对人口统计学(模型 A)、合并症(模型 B)和干预(模型 C)进行了调整:2016 年 10 月至 2020 年 12 月期间,共发现 5,714,993 例主要诊断为急性心肌梗死的入院患者,其中 3,035 例(0.05%)次要诊断为 FH。男性和女性的院内死亡率没有差异(模型 C,调整 OR = 0.85;95% CI 0.28-2.60,p = 0.773)。在次要结果中没有性别差异:结论:尽管FH女性患者一般年龄较大,合并症较多,但她们在急性心肌梗死入院时的死亡率与FH男性患者相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Expert Review of Cardiovascular Therapy
Expert Review of Cardiovascular Therapy CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.70
自引率
0.00%
发文量
82
期刊介绍: Expert Review of Cardiovascular Therapy (ISSN 1477-9072) provides expert reviews on the clinical applications of new medicines, therapeutic agents and diagnostics in cardiovascular disease. Coverage includes drug therapy, heart disease, vascular disorders, hypertension, cholesterol in cardiovascular disease, heart disease, stroke, heart failure and cardiovascular surgery. The Expert Review format is unique. Each review provides a complete overview of current thinking in a key area of research or clinical practice.
期刊最新文献
Risk management of patients with multiple CVDs: what are the best practices? Contemporary review of the evolution of various treatment modalities for mitral regurgitation. Treatment of hypertension in the elderly: target the lowest well tolerated blood pressure. Short-term and long-term outcomes of cardiac arrhythmias in patients with cardiogenic shock. Nattokinase as an adjuvant therapeutic strategy for non-communicable diseases: a review of fibrinolytic, antithrombotic, anti-inflammatory, and antioxidant effects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1